Latest News
WEF applauds China’s commitment to combat COVID | 2022-05-27
Shyam Bishen, head of Shaping the Future of Health and Healthcare at the World Economic Forum (WEF), welcomed China’s calling for the building of “a community of common health for mankind” amid the global public health crisis caused by the COVID-19 pandemic.
Virus nucleic acid degradation disinfectant to hit the market | 2022-05-25
A novel coronavirus (SARS-CoV-2) nucleic acid degradation disinfectant, collaboratively developed by a Shenzhen company, a health institution and a university, is prepared to hit the market.
‘7+7’ quarantine policy adopted for travelers from high-risk areas | 2022-05-24
Travelers arriving in Shenzhen from Shanghai and other high-risk COVID-19 areas must undergo a seven-day centralized quarantine and seven-day home quarantine with nucleic acid testing once a day in the first seven days, and one test on the 10th and 14th day, respectively, according to the COVID travel policy released on the Shenzhen Municipal Health Commission’s official website Sunday.
Chinese oral COVID drug effective against Omicron variant: study | 2022-05-20
Scientists have found in a study that China’s oral COVID-19 nucleoside drug VV116 can shorten the viral shedding time by two to three days in the treatment of patients infected with the Omicron variant of the virus.
SZ’s COVID travel policy updated | 2022-05-19
Travelers arriving in Shenzhen from high-risk COVID-19 areas must undergo a 14-day centralized quarantine and take daily nucleic acid tests during the first seven days and one test on the 10th and 14th day, respectively, according to the COVID travel policy released on the Shenzhen Municipal Health Commission’s official website Tuesday.
Permanent COVID-19 hospitals to be set up: NHC | 2022-05-18
The country plans to build permanent facilities and more COVID-19 test sites to reinforce its capability to prevent and control COVID-19 in the early stage of infection, according to Ma Xiaowei, director of China’s National Health Commission (NHC).
Mosaic vaccine against COVID variants developed by scientists | 2022-05-17
Domestic scientists have developed a mosaic nanoparticle candidate COVID-19 vaccine that can protect against the infections of COVID-19 variants.
Hospitals provide vaccination advice for cancer patients | 2022-05-17
Whether patients with malignant tumors should receive COVID-19 vaccinations depends on their tumor types and therapy plans and stages, according to a paper jointly released by researchers from the Third People’s Hospital of Shenzhen and the Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center.
Half of hospitalized COVID patients ‘report symptom 2 yrs after infection’ | 2022-05-13
The longest follow-up study to date on COVID-19 showed that two years after infection, half of the patients who were admitted to the hospital still have at least one symptom.
China provides over 2.2B COVID vaccine doses to world | 2022-05-12
China had provided more than 2.2 billion doses of COVID-19 vaccine to over 120 countries and international organizations by yesterday, most of which are developing countries, new official data showed.